CIK 0001124524 · Accelerated filer
Cryoport, Inc.
Sign in to watch- Ticker
- CYRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 880313393
- Phone
- (949) 232-1900
- Business address
- 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
- Former names
- CRYOPORT SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,702,237
- in 2 filings, $1.5M under 10b5-1 plans
Net −$1,702,237. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-12 | Hariri Robert J Director | Grant or award · Option (Right to Buy Common Stock) | +15,125 | 15,125 | ||
| 2023-05-12 | HANCOCK DANIEL M Director | Grant or award | +8,105 | 22,643 | ||
| 2023-05-12 | HANCOCK DANIEL M Director | Grant or award · Option (Right to Buy Common Stock) | +15,125 | 15,125 | ||
| 2023-05-12 | BERMAN RICHARD J Director | Grant or award | +8,105 | 108,105 | ||
| 2023-05-12 | BERMAN RICHARD J Director | Grant or award · Option (Right to Buy Common Stock) | +15,125 | 15,125 | ||
| 2023-05-11 | BERMAN RICHARD J Director | Sale | −7,203 | $21.51 | $155K | 100,000 |
| 2023-05-10 | SHELTON JERRELL President, CEO | Option exercise | +286,377 | $3.24 | $928K | 746,458 |
| 2023-05-10 | SHELTON JERRELL President, CEO | Sale | −141,159 | $21.63 | $3.1M | 605,299 |
| 2023-05-10 | SHELTON JERRELL President, CEO | Option exercise · Option to purchase common stock | −286,377 | 0 | ||
| 2023-05-10 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise 10b5-1 | +19,918 | $3.24 | $65K | 127,068 |
| 2023-05-10 | STEFANOVICH ROBERT Chief Financial Officer | Sale 10b5-1 | −19,918 | $21.94 | $437K | 107,150 |
| 2023-05-10 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Options to purchase common stock 10b5-1 | −19,918 | 0 | ||
| 2023-03-22 | STEFANOVICH ROBERT Chief Financial Officer | Grant or award | +10,455 | 107,150 | ||
| 2023-03-22 | STEFANOVICH ROBERT Chief Financial Officer | Grant or award · Stock Option (right to buy) | +20,910 | 20,910 | ||
| 2023-03-22 | SHELTON JERRELL Chief Executive Officer | Grant or award | +27,092 | 460,081 | ||
| 2023-03-22 | SHELTON JERRELL Chief Executive Officer | Grant or award · Stock Option (right to buy) | +60,952 | 60,952 | ||
| 2023-03-22 | Sawicki Mark W Chief Scientific Officer | Grant or award | +10,455 | 72,125 | ||
| 2023-03-22 | Sawicki Mark W Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +20,910 | 20,910 | ||
| 2023-03-15 | BADDOUR LINDA Director | Option exercise | +1,111 | 12,474 | ||
| 2023-03-15 | BADDOUR LINDA Director | Option exercise · Restricted Stock Rights | −1,111 | 1,111 |
Page 12 of 13 · 254 trades